TARS
Tarsus Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Bobak R. Azamian
IPO Date
2020-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Tarsus Pharmaceuticals, Inc.
CEO
Bobak R. Azamian
IPO Date
2020-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US